GoodRx (NASDAQ:GDRX) Trading Up 2% – Still a Buy?

GoodRx Holdings, Inc. (NASDAQ:GDRX)’s stock price was up 2% on Friday . The stock traded as high as $4.64 and last traded at $4.61. Approximately 294,790 shares traded hands during trading, a decline of 79% from the average daily volume of 1,417,572 shares. The stock had previously closed at $4.52.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Citigroup cut their price objective on GoodRx from $10.00 to $7.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Barclays dropped their price target on shares of GoodRx from $10.00 to $6.00 and set an “overweight” rating on the stock in a research report on Monday, November 11th. Mizuho began coverage on shares of GoodRx in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $5.00 price objective for the company. Finally, Morgan Stanley dropped their target price on shares of GoodRx from $7.00 to $6.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $8.37.

GoodRx Stock Up 1.1 %

The company has a current ratio of 5.48, a quick ratio of 5.48 and a debt-to-equity ratio of 0.70. The firm has a market cap of $1.74 billion, a price-to-earnings ratio of -152.33, a PEG ratio of 3.54 and a beta of 1.29. The firm’s 50 day simple moving average is $5.14 and its two-hundred day simple moving average is $6.86.

Institutional Investors Weigh In On GoodRx

A number of hedge funds and other institutional investors have recently made changes to their positions in GDRX. American Century Companies Inc. acquired a new position in GoodRx in the 2nd quarter valued at $18,183,000. Point72 Asset Management L.P. bought a new position in shares of GoodRx in the third quarter worth $11,295,000. Rubric Capital Management LP raised its stake in GoodRx by 76.5% in the second quarter. Rubric Capital Management LP now owns 3,736,802 shares of the company’s stock valued at $29,147,000 after purchasing an additional 1,619,748 shares in the last quarter. Millennium Management LLC lifted its position in GoodRx by 36.5% during the second quarter. Millennium Management LLC now owns 4,121,939 shares of the company’s stock worth $32,151,000 after purchasing an additional 1,102,758 shares during the period. Finally, Franklin Resources Inc. bought a new position in GoodRx in the 3rd quarter valued at about $5,675,000. 63.77% of the stock is currently owned by institutional investors and hedge funds.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.